Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis

BACKGROUND: To verify whether serum levels of reactive oxygen metabolites (ROM) are predictive of future clinical remission in patients with rheumatoid arthritis (RA) receiving tocilizumab (TCZ) therapy. METHODS: A total of 46 patients with RA receiving TCZ therapy were enrolled in this study. Patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Rheumatol
Principais autores: Nakajima, Arata, Terayama, Keiichiro, Sonobe, Masato, Aoki, Yasuchika, Takahashi, Hiroshi, Akatsu, Yorikazu, Saito, Junya, Taniguchi, Shinji, Yamada, Manabu, Kubota, Ayako, Nakagawa, Koichi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912997/
https://ncbi.nlm.nih.gov/pubmed/31891116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-019-0096-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados